Novel approaches in allogeneic stem cell transplantation (Q36562204)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on September 2006

Language	Label	Description	Also known as
English	Novel approaches in allogeneic stem cell transplantation	scientific article published on September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Novel approaches in allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

author name string

Esperanza B Papadopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Ann A Jakubowski

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Current Oncology Reports

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

325-336

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Identical-twin bone marrow transplants for leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-006-0054-0

21 January 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://api.crossref.org/works/10.1007%2FS11912-006-0054-0

21 January 2018

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloablative conditioning is well tolerated by older patients receiving T-cell-depleted grafts

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular adoptive immunotherapy after allogeneic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing engraftment--source and dose of stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16901394

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11912-006-0054-0

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36562204&oldid=2199036847"